S01 The Science of Therapy for Infectious Diseases S02 New System for Pharmacy Education: The Pharmaceutical Common Achievement Tests, the Third-party Evaluation of Pharmacy Education, and the National Examination for Pharmacist License S03 Continuous Pharmaceutical Recurrent Education to Support Community Healthcare S04 Estimation of Outcome after Intervention of Pharmacy Specialist in Pharmaceutical Care Services S05 DRUG RE-PROFILING（Eco-Pharma）— Identification of New Applications of Existing Medicines— S06 Making the Best Use of Health/Pharmaceutical Information Medical Service S07 Primary Care Pharmacist and Pharmacy S08 Contribution to the Community through the Social Activities by Pharmacy Students S09 Survival Ability of Pharmacy Graduate Learned in the Society —Proposals for 6 yr Education S10 Establishment of Novel Therapeutic Technologies by the Fusion of Medical Technologies in Various Fields S11 Is the Life Cycle Management of Medicine Is Really Useful for Quality of Life in Patients? S12 Pharmacometrics— The Gate to Inspire Confidence and Guarantee of Pharmaceuticals S13 Pharmacogenomics Study to Avoid Serious Drug Adverse Reactions S14 Utilization of Large-scale Postmarketing Adverse Event Data for Pharmacovigilance —Rational Use and Safety Information of Psychotropic Drugs— S15 Challenging the Development of New Anti-Diabetic Medicines by Using Approaches from Educational, Clinical, and Research Fields S16 Current State and View of Pharmaceutical and Medicine Industry that 6 Year-educated Pharmacists Request and Are Requested S17 Learning Together, Teaching Together: Making Experiential Pharmacy Practice a Success S18 Recent Topics of NanoTox Studies for Their Safety S19 Development of Cellular and Gene Therapy Products for Bioactive Protein-Based Therapy S20 Relief and Safety to Pharmacogenomics ∼Can a Pharmacist Take the Responsibility for Management of Pharmacogenomics? ∼ S21 Recent Development of "Ultra-Orphan Drug" Research for Lysosomal Storage Diseases S22 Pathogenic Mechanism, Diagnosis and Therapy of Alzheimer's Disease: Current Understanding and Perspective S23 The Present and Future of Communication Studies in the Six-year System S24 Education of Graduate School of Pharmaceutical Sciences in New Generation S25 On the Way to New Pharmacy Education—Action of Young Educators and Reactions from Students S26 What Medicinal Chemistry Should Be in the New System of Pharmaceutical Education? S27 Towards the Creation of the Next-Generation, High Performance Catalysts S28 Molecular Imaging with PET/SPECT/CT Devices for Small Animals to Promote Drug Development S29 Novel Molecular Imaging by Making Full Use of Organic Chemistry S30 The Front of Neurometal Research∼Role of Metals in Brain Functions and Brain Diseases∼ S31 The Origin and Future of Organic Chemistry in Pharmaceutical Sciences S32 Why Don't You Reconfirm about "Food Safety"? S33 Molecular Toxicology Leaded by Young Scientists 5 ∼Biological Systems to Determine the Sensitivity to Chemicals∼ S34 Power of Natural Products 2 S35 The Industrial Aspects of Process Chemistry S36 Chemical Biology for Pharmaceutical Sciences (Molecular Design toward Exploration of Biological Functions) S37 Analytical Sciences for Health, Safety and Security S38 Practical Drug Development Based on Organic Chemistry S39 Organocatalyst: Now and Future S40 Pharmaceuticals in Water Environment and Its Effects on Aquatic Ecosystem S41 New Approaches in Toxicometallomics—Incubation of Analytical and Imaging Techniques with Metal-Related Diseases and Therapies S42 New Analytical Method for Observing, Measuring, and Understanding Biological Molecules and Cells S43 Synthetic Organic Chemistry in Drug Discovery: New Concept and Methodology for the Construction of Organic Molecules S44 Novel Influenza —Review of the Recent Pandemic of the Novel Influenza (H1N1) — S45 A Heritage of Pharmacognosy and Its Innovation—Trials from Academic, Investigative and Clinical Perspective S46 Local Dynamics of Prostaglandins as New Drug Targets: From Their Biosynthesis to Metabolism S47 The Establishment of "Evidence Based Medicine" for the Treatment of Cerebral Stroke —Bridging Basic and Clinical Sciences — S48 New Development of Histamine Research in Allergic Inflammation S49 New Challenges for the Control of Influenza S50 Perspective on G Protein-coupled Receptors from Their Structure, Function, Complex Formation, Modeling and Ligand Development S51 A View of Epilepsy Study: A Development for New Anti-Epileptic Drugs S52 Signal Transduction in the Development of Vascular Disease and New Therapeutic Strategy S53 Recent Advances in Mast Cell Research S55 The Frontiers of White Biotechnology and the Development of Pharmaceutical Sciences S56 Recent Development in Blood Coagulation Factors, Coagulation-related Drugs and Blood Products S57 Defensive' Ion Channels as Potential Therapeutic Targets S58 In Search of New Perspective on Pharmacology in Pharmaceutical Sciences S59 Front Lines of RNA Research: From Molecular Basis of Regulation of RNA Dynamics to Development of New Drugs S60 Biological Regulation by Decoding Genetic Information S61 Novel Approaches to Brain Diseases by Young Pharmacologists: From Molecular to Behavioral Analyses for Discovering Potential Drug Targets MS01 Drug Discovery and Development of Chronotherapy Based on the Biological Clock MS02 The Frontline and Possibility of New Drug Development Targeting Glial Functions MS03 Patient Consent and the Drug Safety of Investigational Products and Approved Drugs MS04 Special Symposium “Biofunction and Molecular Imaging on Biomolecules" MS05 Transporter: Boundary of the Membrane Transports Xenobiotics and Nutrients MS06 Brain Function and Disorder —From Molecule to Behavior— MS07 Drug Discovery and Clinical Evaluation MS08 The Power of Organic Chemistry to Evolute and Deepen New Drug Development MS09 The Usefulness of Monkeys in the Evaluation of Pharmacokinetics and Toxicity of Drug Candidates MS10 New Perspective on Molecular-Targeted Therapy GS01 Next Generation of DDS and Formulation Technologies for Drug Discovery GS02 The Challenge for Development of Biotechnology-based Medicine by Young Scientists GS03 Trend in Environmental and Molecular Pharmaceutical Sciences GS04 The Power of Young Researchers Responsible for Medicinal Chemistry in Following Generation GS05 Pharmacologic Research for Leading to Drug Development and Treatment Strategy ∼Pharmacological Approach to Treatment by Clarification of the Pathology∼ SS01 Taste and Health: Nutritional and Physiological Significances of Taste Substances in Daily Foods SS02 The Front of Synchrotron Application for Organic Chemists - Structure Determination Used Micro Crystals and Powder (SPring-8 7th Meeting of Organic/Powder Structure Determination Society) SS03 Current Trends of Theoretical and Medicinal Chemistry